ARZNEIMITTELABGABEVORRICHTUNG

Patent europeic · EP3895747 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3895747
Numer da la dumonda
EP21178270
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
29-08-2013
Publitgà
20-10-2021
Concedì
24-12-2025
La protecziun finescha il pli tard
28-08-2033
Proxima taxa annuala scadenta
31-08-2027
Classas IPC
A61M 5/315 (2006.01)
A61M 5/24 (2006.01)
A61M 5/31 (2006.01)
Prioritad
EP 12182568 31.08.2012
US 201261697078 P 05.09.2012
Derivà da
EP20157230
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-09-2026

    Next annual fee due on

    Next annual fee due on
    31.08.2026 → 31.08.2027

    Published in Swissreg on 01.09.2026

  2. 24-12-2025

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 24.12.2025

Partidas

Possessur

Sanofi-Aventis Deutschland GmbH

Brüningstraße 50, 65929 Frankfurt am Main, DE

Inventur

Plumptre, David Aubrey

Warwick, CV34 4AB, GB

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.